Articles tagged "Kidney transplantation"

2018 American Transplant Congress
The Incidence and Outcome of Isolated Distal Deep Vein Thrombosis in Kidney Transplant Recipient
M. Kim, J. Hwang, S. Kim, S. Park, I. Moon, J. Kim.
Surgery, The Catholic University of Korea, Seoul, Republic of Korea.
Introduction Isolated distal deep vein thrombosis (IDDVT) in kidney transplantation recipient (KTR) is difficult to make decision because it is not common in Korean and…
2018 American Transplant Congress
Hispanics' Perceptions of a Culturally Targeted Transplant Program: A Mixed Methods Study
N. Alhalel,¹ N. Francone,¹ J. Caicedo,¹ R. Ruiz,² A. Salazar,² S. Primeaux,² E. Gordon.¹
¹Northwestern University, Chicago, IL; ²Baylor University Medical Center, Dallas, TX.
Background: Although Hispanics have a disproportionally higher prevalence of end-stage renal disease than non-Hispanic whites, fewer waitlisted Hispanics receive living donor kidney transplants (LDKTs). Northwestern…
2018 American Transplant Congress
Characterization of Renal Allograft Tolerance Induction via Transient Mixed Chimerism in Non-Human Primates
H. Sasaki,¹ C. Thaiss,¹ T. Oura,¹ A. Rosales,² R. Smith,² R. Colvin,² B. Cosimi,¹ T. Kawai.¹
¹Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Boston; ²Pathology, Massachusetts General Hospital, Boston.
Background: We have previously reported long-term renal allograft tolerance after induction of transient mixed chimerism in non-human primates. However, some recipients developed late onset chronic…
2018 American Transplant Congress
Kidney Graft Outcomes in Combined Heart-Kidney Transplantation: A UNOS Database Analysis 2000-2015
A. Riaz, O. Adebiyi, D. Mishler, M. Yaqub, T. Taber, A. Sharfuddin.
Indiana University, Indianapolis.
Background: Combined Heart-Kidney Transplantation (CHKT) is the optimal therapy for patients with advanced renal dysfunction. Our aim was to analyze kidney specific graft outcomes in…
2018 American Transplant Congress
Two Decades of Eurotransplant Senior Program (ESP): Time on Dialysis Independently Impacts Patient Survival, Allograft Survival and Quality of Life after Kidney Transplantation
T. Schachtner,^1,2,3 N. Otto,¹ P. Reinke.^1,2
¹Nephrology and Internal Intensive Care, Charite Campus Virchow Clinic, Berlin, Germany; ²Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charite Campus Virchow Clinic, Berlin, Germany; ³Berlin Institute of Health (BIH), Charite and Max Delbrueck Center, Berlin, Germany.
In 1999, the Eurotransplant Senior Program (ESP) was implemented and allocates kidneys from deceased-donors ≥65 years to kidney transplant recipients ≥65 years (ESP-KTRs). The ESP…
2018 American Transplant Congress
Reliability of Deceased Donor Procurement Biopsy Images at the Time of Kidney Allocation
S. Mansour,¹ E. Hall,² P. Reese,³ Y. Jia,¹ H. Thiessen-Philbrook,¹ G. Moeckel,¹ F. Weng,⁴ P. Revelo,² M. Khalighi,² A. Trivedi,⁵ M. Doshi,⁶ B. Schroppel,⁷ C. Parikh.¹
¹Yale University School of Medicine, New Haven; ²University of Utah School of Medicine, Salt Lake City; ³Perelman School of Medicine at the University of Pennsylvania, Philadelphia; ⁴Saint Barnabas Medical Center, Livingston; ⁵Hartford Hospital, Hartford; ⁶Wayne State University, Detroit; ⁷University Hospital, Ulm, Germany.
Histological findings of procurement deceased-donor kidney biopsies contribute to organ allocation decisions. Representative images of pathology on biopsy slides are often uploaded into United Network…
2018 American Transplant Congress
Anti-Thymocyte Globulin vs. Alemtuzumab: A Comparison of Long-Term Outcomes among Renal Transplant Recipients
E. Loncharic, A. Dodson, K. Gutierrez.
Department of Pharmacy, The University of Alabama at Birmingham, Birmingham, AL.
Background: Two lymphocyte depleting agents are currently available for renal transplant induction: alemtuzumab (C1H) and rabbit anti-thymocyte globulin (rATG). Studies comparing long-term outcomes between C1H…
2018 American Transplant Congress
High Prevalence of Kidney Transplant-Associated Thrombotic Microangiopathy after ABO-Incompatible Kidney Transplantation: Risk Factors, Rapid Clinical Diagnosis, and Prompt Successful Treatment
K. Tanabe,¹ M. Okumi,¹ K. Unagami,² Y. Kakuta,¹ M. Inui,¹ H. Ishida.¹
¹Urology, Tokyo Women's Medical University, Tokyo, Japan; ²Nephrology, Tokyo Women's Medical University, Tokyo, Japan.
BackgroundKidney transplant-associated thrombotic microangiopathy (KTA-TMA) is a multifactorial inflammatory disorder and thrombotic disease of the microvasculature. It is characterized by hemolytic anemia, thrombocytopenia, and acute…
2018 American Transplant Congress
Transplantation Tourism and Recipients Perspectives and Experience
F. Al Rahbi, I. Al Salmi.
The Renal Medicine Department, The Royal Hospital, Muscat, Oman.
Background: In view of shortages of available organs, long wait times for possible transplantation and strict regulation, many patients opt for commercial transplantation. This study…
2018 American Transplant Congress
Single-Dose Pharmacokinetics and Pharmacodynamics of Belatacept in Adolescent Kidney Transplant Recipients
A. Moudgil,¹ V. Dharnidharka,² D. Feig,³ B. Warshaw,⁴ V. Perera,⁵ B. Murthy,⁵ M. Roberts,⁵ M. Polinsky,⁵ R. Ettenger.⁶
¹Children's National Medical Center, Washington, DC; ²Washington University, St. Louis, MO; ³University of Alabama, Birmingham, AL; ⁴Emory University & Children's Healthcare of Atlanta, Atlanta, GA; ⁵Bristol-Myers Squibb, Lawrenceville, NJ; ⁶University of California, Los Angeles, CA.
Purpose: To assess the pharmacokinetics (PK) and pharmacodynamic (PD) effect of a single dose of belatacept (bela) administered to adolescent kidney transplant recipients (KTR).Methods: In…